Watchlist Manager

Watchlist

Price: 15.89 USD Market Closed

Market Cap: $14.9B

S	Sino Biopharmaceutical Ltd OTC:SBHMY	HK
R	Rumere Co Ltd SZSE:301088	CN

Income Statement

Currency: CNY

	Dec-2000	Mar-2001	Jun-2001	Sep-2001	Dec-2001	Mar-2002	Jun-2002	Sep-2002	Dec-2002	Mar-2003	Jun-2003	Sep-2003	Dec-2003	Dec-2004	Jun-2005	Sep-2005	Dec-2005	Jun-2006	Sep-2006	Dec-2006	Jun-2007	Dec-2007	Jun-2008	Dec-2008	Jun-2009	Dec-2009	Jun-2010	Dec-2010	Jun-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Dec-2021	Jun-2022	Dec-2022	Jun-2023	Dec-2023	Jun-2024	Dec-2024	Jun-2025	Dec-2025
Revenue
Interest Expense	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	3	0	0	2	0	3	4	8	1	2	1	5	4	9	0	5	0	8	0	0	0	2	0	0	0	34	0	0	0	65	0	0	0	77	0	0	0	78	0	0	0	153	0	0	0	230	0	0	0	323	0	0	309	169	429	554	495	345	295	0	0
Revenue	413 N/A	450 +9%	478 +6%	524 +10%	563 +7%	586 +4%	635 +8%	707 +11%	735 +4%	815 +11%	827 +1%	860 +4%	873 +1%	1 116 +28%	394 -65%	634 +61%	796 +25%	601 -24%	572 -5%	754 +32%	683 -9%	1 135 +66%	796 -30%	2 037 +156%	1 207 -41%	2 858 +137%	1 380 -52%	3 560 +158%	1 833 -49%	4 801 +162%	3 456 -28%	3 844 +11%	5 650 +47%	6 772 +20%	6 841 +1%	7 369 +8%	7 663 +4%	7 847 +2%	8 298 +6%	8 758 +6%	9 236 +5%	10 940 +18%	10 545 -4%	11 103 +5%	11 777 +6%	12 165 +3%	12 289 +1%	12 582 +2%	13 013 +3%	13 543 +4%	13 899 +3%	14 258 +3%	14 540 +2%	14 819 +2%	15 609 +5%	17 062 +9%	19 103 +12%	20 889 +9%	22 444 +7%	23 691 +6%	24 479 +3%	24 234 -1%	24 248 +0%	24 354 +0%	23 039 -5%	23 647 +3%	24 668 +4%	25 353 +3%	26 861 +6%	42 055 +57%	26 026 -38%	25 116 -3%	26 199 +4%	26 797 +2%	28 866 +8%	30 567 +6%	31 834 +4%
Gross Profit
Cost of Revenue	(88)	(92)	(97)	(102)	(108)	(112)	(123)	(140)	(154)	(176)	(173)	(183)	(179)	(198)	(74)	(126)	(147)	(110)	(101)	(142)	(122)	(201)	(152)	(422)	(242)	(564)	(238)	(684)	(366)	(1 032)	(720)	(781)	(1 147)	(1 400)	(1 411)	(1 556)	(1 648)	(1 766)	(1 893)	(1 978)	(2 087)	(2 581)	(2 479)	(2 660)	(2 819)	(2 717)	(2 729)	(2 717)	(2 732)	(2 817)	(2 876)	(2 932)	(3 021)	(3 091)	(3 224)	(3 381)	(3 781)	(4 197)	(4 468)	(4 791)	(4 881)	(4 926)	(4 980)	(5 266)	(5 230)	(5 182)	(5 331)	(5 143)	(5 332)	(8 292)	(4 488)	(4 128)	(4 990)	(4 578)	(5 336)	(5 573)	(5 708)
Gross Profit	324 N/A	357 +10%	382 +7%	422 +11%	455 +8%	473 +4%	513 +8%	567 +11%	581 +2%	640 +10%	654 +2%	677 +4%	694 +2%	918 +32%	320 -65%	509 +59%	649 +28%	491 -24%	471 -4%	611 +30%	561 -8%	934 +66%	644 -31%	1 615 +151%	965 -40%	2 294 +138%	1 142 -50%	2 876 +152%	1 467 -49%	3 769 +157%	2 736 -27%	3 062 +12%	4 503 +47%	5 372 +19%	5 430 +1%	5 814 +7%	6 016 +3%	6 081 +1%	6 405 +5%	6 780 +6%	7 149 +5%	8 359 +17%	8 066 -4%	8 443 +5%	8 958 +6%	9 448 +5%	9 561 +1%	9 865 +3%	10 281 +4%	10 727 +4%	11 023 +3%	11 326 +3%	11 520 +2%	11 729 +2%	12 385 +6%	13 681 +10%	15 322 +12%	16 692 +9%	17 976 +8%	18 900 +5%	19 598 +4%	19 308 -1%	19 268 0%	19 088 -1%	17 809 -7%	18 465 +4%	19 337 +5%	20 210 +5%	21 529 +7%	33 763 +57%	21 539 -36%	20 988 -3%	21 210 +1%	22 219 +5%	23 530 +6%	24 994 +6%	26 127 +5%
Operating Income
Operating Expenses	(236)	(256)	(274)	(302)	(339)	(347)	(370)	(415)	(436)	(481)	(500)	(504)	(516)	(636)	(243)	(378)	(458)	(340)	(316)	(400)	(383)	(677)	(388)	(1 137)	(621)	(1 608)	(812)	(2 107)	(1 127)	(2 972)	(2 135)	(2 383)	(3 393)	(3 988)	(4 112)	(4 466)	(4 634)	(4 671)	(4 893)	(5 140)	(5 303)	(6 317)	(6 151)	(6 456)	(6 792)	(7 052)	(7 152)	(7 243)	(7 580)	(7 934)	(8 064)	(8 256)	(8 261)	(8 436)	(8 734)	(9 624)	(10 509)	(12 295)	(13 376)	(14 148)	(14 980)	(14 061)	(14 100)	(13 793)	(13 118)	(14 094)	(14 663)	(15 090)	(16 750)	(26 096)	(15 846)	(15 219)	(15 264)	(16 034)	(17 437)	(19 705)	(19 538)
Selling, General & Administrative	(232)	(258)	(277)	(306)	(336)	(354)	(376)	(422)	(418)	(464)	(483)	(491)	(483)	(605)	(235)	(354)	(444)	(367)	(371)	(461)	(393)	(642)	(437)	(1 055)	(643)	(1 502)	(778)	(1 932)	(966)	(2 536)	(1 892)	(2 148)	(3 039)	(3 567)	(3 579)	(3 844)	(3 995)	(4 004)	(4 218)	(4 307)	(4 470)	(5 451)	(5 247)	(5 473)	(5 867)	(5 962)	(5 980)	(6 136)	(6 218)	(6 493)	(6 525)	(6 668)	(6 704)	(6 905)	(7 334)	(7 921)	(8 799)	(10 268)	(11 036)	(11 801)	(12 544)	(11 797)	(11 762)	(11 490)	(11 086)	(11 629)	(12 142)	(12 588)	(12 764)	(19 638)	(11 709)	(11 001)	(11 067)	(11 470)	(12 159)	(12 855)	(13 491)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1 595)	(612)	(1 328)	(1 703)	(2 091)	(2 343)	(2 388)	(2 442)	(2 399)	(2 508)	(2 314)	(2 271)	(2 627)	(2 667)	(2 868)	(3 677)	(5 726)	(4 164)	(4 441)	(4 403)	(4 624)	(5 089)	(5 698)	(5 866)
Other Operating Expenses	(3)	2	3	3	(3)	7	6	6	(18)	(17)	(17)	(14)	(33)	(31)	(8)	(23)	(14)	27	55	62	10	(36)	49	(82)	23	(106)	(34)	(176)	(162)	(436)	(243)	(235)	(353)	(421)	(532)	(622)	(639)	(667)	(674)	(834)	(833)	(866)	(904)	(984)	(926)	(1 089)	(1 171)	(1 107)	(1 362)	(1 442)	(1 539)	(1 588)	(1 557)	64	(788)	(375)	(8)	64	3	41	7	135	171	11	239	162	147	365	(309)	(733)	27	223	206	60	(189)	(1 152)	(181)
Operating Income	89 N/A	102 +15%	108 +6%	120 +11%	116 -3%	126 +9%	142 +13%	152 +7%	145 -4%	158 +9%	154 -3%	173 +12%	178 +3%	283 +59%	77 -73%	131 +69%	191 +46%	151 -21%	155 +3%	212 +37%	178 -16%	257 +44%	256 0%	478 +87%	344 -28%	687 +100%	330 -52%	770 +133%	340 -56%	797 +135%	601 -25%	679 +13%	1 111 +64%	1 384 +25%	1 319 -5%	1 348 +2%	1 381 +2%	1 411 +2%	1 512 +7%	1 639 +8%	1 845 +13%	2 042 +11%	1 915 -6%	1 987 +4%	2 166 +9%	2 396 +11%	2 409 +1%	2 622 +9%	2 700 +3%	2 793 +3%	2 959 +6%	3 070 +4%	3 259 +6%	3 293 +1%	3 651 +11%	4 056 +11%	4 813 +19%	4 397 -9%	4 601 +5%	4 752 +3%	4 618 -3%	5 247 +14%	5 168 -2%	5 296 +2%	4 691 -11%	4 371 -7%	4 674 +7%	5 119 +10%	4 779 -7%	7 667 +60%	5 693 -26%	5 769 +1%	5 946 +3%	6 184 +4%	6 093 -1%	5 289 -13%	6 589 +25%
Pre-Tax Income
Interest Income Expense	2	(3)	(3)	(2)	9	(2)	(2)	(2)	(1)	(1)	(1)	(2)	6	52	(1)	(2)	(73)	(72)	(72)	(2)	39	77	(33)	58	(31)	16	10	178	150	30	73	122	46	69	174	191	248	252	248	271	285	426	398	518	477	483	450	372	386	408	406	433	592	901	902	851	641	475	384	315	407	443	575	371	326	637	1 938	8 312	14 433	14 664	(452)	(1 187)	(505)	(341)	233	2 757	415
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	2	0	0	0	31	0	0	0	8	0	0	0	0	0	0	3	3	40	4	2	2	(35)	2	2	6 557	6 599	6 598	6 613	1	1	1	(15)	5	5	6	(639)	(4)	(26)	(68)	(30)	(43)	(1 048)	(416)	(61)
Total Other Income	0	0	(0)	(0)	(0)	0	0	(0)	0	0	0	0	0	0	0	0	0	(0)	(0)	0	0	0	0	0	(1)	0	0	0	0	0	0	0	88	0	0	0	0	(1)	0	0	0	0	0	(0)	0	0	0	0	0	0	0	0	0	0	(0)	(0)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Pre-Tax Income	91 N/A	99 +9%	104 +6%	118 +13%	125 +6%	124 -1%	141 +13%	149 +6%	144 -4%	157 +9%	153 -3%	172 +13%	184 +7%	335 +82%	77 -77%	129 +68%	118 -9%	79 -33%	83 +5%	210 +153%	217 +3%	334 +54%	224 -33%	536 +140%	312 -42%	705 +126%	341 -52%	948 +178%	489 -48%	827 +69%	673 -19%	800 +19%	1 245 +56%	1 455 +17%	1 492 +3%	1 539 +3%	1 629 +6%	1 693 +4%	1 761 +4%	1 910 +9%	2 130 +11%	2 476 +16%	2 313 -7%	2 505 +8%	2 642 +5%	2 879 +9%	2 859 -1%	2 995 +5%	3 089 +3%	3 203 +4%	3 405 +6%	3 506 +3%	3 852 +10%	4 196 +9%	4 519 +8%	4 909 +9%	5 456 +11%	11 429 +109%	11 583 +1%	11 665 +1%	11 638 0%	5 691 -51%	5 744 +1%	5 668 -1%	5 002 -12%	5 013 +0%	6 618 +32%	13 437 +103%	18 573 +38%	22 327 +20%	5 215 -77%	4 514 -13%	5 410 +20%	5 800 +7%	5 277 -9%	7 630 +45%	6 943 -9%
Net Income
Tax Provision	(7)	(7)	(7)	(7)	(9)	(10)	(12)	(13)	(18)	(19)	(19)	(22)	(25)	(32)	(5)	(8)	(19)	(10)	(14)	(23)	(33)	(33)	(42)	(106)	(41)	(119)	(51)	(199)	(95)	(138)	(92)	(169)	(257)	(302)	(296)	(261)	(264)	(281)	(301)	(330)	(345)	(389)	(367)	(378)	(436)	(446)	(446)	(445)	(473)	(475)	(516)	(541)	(567)	(542)	(545)	(686)	(822)	(696)	(750)	(717)	(744)	(903)	(907)	(999)	(857)	(672)	(911)	(1 471)	(1 958)	(2 529)	(697)	(623)	(797)	(887)	(493)	(860)	(1 629)
Income from Continuing Operations	83	91	97	110	116	115	129	136	126	138	134	150	159	303	72	122	99	69	69	188	184	301	181	430	271	586	290	749	394	688	582	631	987	1 153	1 196	1 278	1 365	1 412	1 460	1 580	1 785	2 087	1 945	2 126	2 206	2 434	2 413	2 550	2 616	2 729	2 889	2 965	3 285	3 654	3 974	4 224	4 634	10 733	10 833	10 948	10 894	4 788	4 837	4 668	4 146	4 341	5 706	11 966	16 615	19 798	4 518	3 891	4 613	4 913	4 785	6 770	5 315
Income to Minority Interest	(36)	(38)	(42)	(49)	(51)	(54)	(61)	(64)	(65)	(67)	(63)	(70)	(73)	(124)	(67)	(112)	(126)	(69)	(35)	(43)	(46)	(82)	(58)	(165)	(118)	(236)	(116)	(255)	(128)	(304)	(212)	(229)	(354)	(428)	(425)	(449)	(489)	(591)	(588)	(642)	(707)	(749)	(684)	(682)	(804)	(947)	(866)	(979)	(996)	(1 091)	(1 100)	(1 103)	(1 142)	(1 483)	(1 611)	(1 788)	(2 067)	(1 686)	(1 701)	(1 823)	(1 794)	(2 026)	(2 056)	(2 110)	(1 761)	(1 570)	(1 870)	(1 928)	(2 006)	(3 269)	(2 459)	(2 638)	(2 765)	(2 914)	(2 865)	(2 872)	(2 971)
Net Income (Common)	48 N/A	54 +13%	56 +4%	62 +11%	66 +6%	61 -8%	69 +13%	72 +5%	61 -15%	71 +16%	71 +0%	80 +12%	87 +9%	179 +106%	89 -50%	1 623 +1 728%	1 614 -1%	1 527 -5%	31 -98%	145 +363%	138 -5%	219 +59%	124 -44%	266 +115%	153 -42%	350 +129%	174 -50%	494 +184%	266 -46%	384 +44%	370 -4%	402 +9%	633 +57%	724 +14%	771 +6%	829 +8%	877 +6%	822 -6%	872 +6%	938 +8%	1 078 +15%	1 337 +24%	1 261 -6%	1 444 +14%	1 402 -3%	1 487 +6%	1 546 +4%	1 572 +2%	1 620 +3%	1 637 +1%	1 789 +9%	1 862 +4%	2 143 +15%	2 171 +1%	2 363 +9%	2 436 +3%	2 567 +5%	9 046 +252%	9 132 +1%	9 125 0%	9 101 0%	2 762 -70%	2 781 +1%	2 558 -8%	2 384 -7%	2 771 +16%	3 836 +38%	10 038 +162%	14 608 +46%	16 529 +13%	2 544 -85%	1 881 -26%	2 332 +24%	4 090 +75%	3 500 -14%	3 871 +11%	2 343 -39%
EPS (Diluted)	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0.01 N/A	0 N/A	0 N/A	0 N/A	0.01 N/A	0.02 +100%	0 N/A	0.16 N/A	0.16 N/A	0.14 -12%	0 N/A	0.01 N/A	0.01 N/A	0.02 +100%	0.02 N/A	0.03 +50%	0.02 -33%	0.03 +50%	0.02 -33%	0.05 +150%	0.03 -40%	0.03 N/A	0.03 N/A	0.03 N/A	0.05 +67%	0.07 +40%	0.07 N/A	0.08 +14%	0.03 -63%	0.07 +133%	0.06 -14%	0.08 +33%	0.09 +12%	0.12 +33%	0.12 N/A	0.14 +17%	0.13 -7%	0.13 N/A	0.14 +8%	0.14 N/A	0.15 +7%	0.1 -33%	0.16 +60%	0.17 +6%	0.19 +12%	0.13 -32%	0.21 +62%	0.18 -14%	0.22 +22%	0.49 +123%	0.48 -2%	0.48 N/A	0.48 N/A	0.15 -69%	0.15 N/A	0.14 -7%	0.13 -7%	0.15 +15%	0.2 +33%	0.52 +160%	0.75 +44%	0.86 +15%	0.13 -85%	0.1 -23%	0.12 +20%	0.22 +83%	0.19 -14%	0.22 +16%	0.13 -41%

Income Statement Balance Sheet Cash Flow Statement

Sino Biopharmaceutical Ltd
OTC:SBHMY

Income Statement

Earnings Waterfall
Sino Biopharmaceutical Ltd

Income Statement
Sino Biopharmaceutical Ltd

See Also

Company

Help

Tools

Stocks

Sino Biopharmaceutical Ltd OTC:SBHMY

Income Statement

Earnings Waterfall Sino Biopharmaceutical Ltd

Income Statement Sino Biopharmaceutical Ltd

See Also

Company

Help

Tools

Stocks

Sino Biopharmaceutical Ltd
OTC:SBHMY

Earnings Waterfall
Sino Biopharmaceutical Ltd

Income Statement
Sino Biopharmaceutical Ltd